Abstract
Objective: To estimate the impact of autologous transfusion on the status of perioperative immune activation in malignant tumor patients. The Serum Neopterin and Interleukin-2 (IL-2) were measured. Methods: Sixty patients undergoing elective radical resection for malignant stomach tumor were enrolled in the prospective study and assigned to the following groups: (1) Group A received autologous transfusion; (2) Group H received allogeneic transfusion. The perioperative course (Before induction of anesthesia, after operation and 5 d after operation) of Neopterin and IL-2 was compared. Results: In group A, Serum Neopterin was significantly lower than baseline after operation and IL-2 had no significant changes. In group H, both Serum Neopterin and IL-2 were significantly lower than baseline after operation and 5 d after operation. Compared with group A, Serum Neopterin was significantly lower than baseline after operation and 5 d after operation and IL-2 was significantly lower than baseline 5 d after operation. Conclusion: Autologous transfusion decreased the perioperative immune suppression in malignant stomach tumor patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gurlo, T., Huang, W.W., von-Grafenstein, H., 1998. PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells.Cytokine,10:265–274.
Haupt, W., Riese, J., Mehler, C., 1998. Monocyte function before and after surgical trauma.Dig Surg,15:102–104.
Heiss, M.M., Merten, K., Allgayer, H., 1997. Influence of autologous blood transfusion on NK and LAK cell activities in cancer surgery.Vox Sang,73:237–245.
Immanuel, C., Swamy, R., Kannapiran, M., Vijayalakshmi, S., Sundaram, V., Jagannath, K., 1997. Neopterin as a marker for cell-mediated immunity in patients with pulmonary tuberculosis.Int J Tuberc Lung Dis,1(2):175–180.
Landers, D., Hill, G., Wong, K.C., 1996. Blood transfusion-induced immunomodulation.Anesth Analg,82:187–204.
Liberman, A.C., Refojo, D., Arzt, E., 2003. Cytokine signaling/transcription factor cross-talk in T cell activation and Thl-Th2 differentiation.Arch Immunol Ther Exp (Warsz),51:351–365.
Lissoni, P., Barni, S., Di-Felice, G., Majorca, F., Fumagalli, L., 1997. Neopterin, soluble IL-2 receptor and IL-6 secretion during IL-2 cancer immunotherapy: prognostic significance in relation to IL-12 variations.Int J Biol Markers,12(3):134–136.
Rubin, J.T., 1995. Interleukin-2: its rationale and role in the treatment of patients with cancer.Cancer Treat Res,80:83–105.
Wachter, H., Fuchs, D., Hausen, A., 1989. Neopterin as marker for activation of cellular immunity: immunological basis and clinical application.Adv Clin Chem,27:81–91.
Weisbach, V., Wanke, C., Zingsem, J., 1999. Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates.Vox Sang,76:100–106.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project (No. 1121) supported by Zhejiang Province Health Bureau, China
Rights and permissions
About this article
Cite this article
Yan, M., Chen, G., Fang, Ll. et al. Immunologic changes to autologous transfusion after operational trauma in malignant tumor patients: Neopterin and Interleukin-2. J Zheijang Univ Sci B 6, 49–52 (2005). https://doi.org/10.1631/jzus.2005.B0049
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.2005.B0049